European Medicines Agency (EMA)
Faster drug access as Dutch reduce assessment time for costly medicines [Advocacy Lab]
The Dutch Healthcare Institute says it does not strive for 100% availability of new drugs, but focuses on rapid access to quality care
![Faster drug access as Dutch reduce assessment time for costly medicines [Advocacy Lab]](https://www.rivonews.online/wp-content/uploads/2026/05/GettyImages-2217256698-1182x788-1-800x480.jpg)